• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Oncology division

So you are saying the big pharma culture is better than the startup biotech’s?

You are insane if you think that.
Well some have been great and some have sucked….a lot like big pharma Yes I have been in all of those situations over the past 20 years.

I didn’t go to a startup for the culture, I went for money. Go ask stemline and their psycho leader. She is a treat. They paid thru nose because culture sucks.
 








Well some have been great and some have sucked….a lot like big pharma Yes I have been in all of those situations over the past 20 years.

I didn’t go to a startup for the culture, I went for money. Go ask stemline and their psycho leader. She is a treat. They paid thru nose because culture sucks.


They actually didn’t pay that well…compared to other biotechs. You must have worked at some crappy biotechs if you didn’t see the cultures as being better.
 




They actually didn’t pay that well…compared to other biotechs. You must have worked at some crappy biotechs if you didn’t see the cultures as being better.
Well actually I have and if you read what I said, some have been a blast and some have really sucked. Just like big pharma cultures. Gene was big pharma both you didn’t feel that way.
 




Well actually I have and if you read what I said, some have been a blast and some have really sucked. Just like big pharma cultures. Gene was big pharma both you didn’t feel that way.


IF, and that is a huge IF, you worked at DNA (which is what people who actually worked there abbreviate it as - not Gene) I guarantee you were there well after the Roche buyout...I worked on TPA (yes before Genentech had an oncology product) and then went on to launch Avastin, Rituxan, and Herceptin. I was there for the 25th anniversary party...guessing you were not.

So sure if you saying you worked at Genentech post the Roche buyout, that means you never really worked for Genentech, you worked for Roche, and after the buyout all the good people left - and yes that was 'big pharma', hence why all the good people left. Please don't confuse that with what was an amazing oncology biotech culture before the buyout...

Thanks for playing...any other 'startup biotechs' you worked at? And what I mean by that, is you were actually part of the 'start up' part...not the come in 5 to 10 years later part.
 




IF, and that is a huge IF, you worked at DNA (which is what people who actually worked there abbreviate it as - not Gene) I guarantee you were there well after the Roche buyout...I worked on TPA (yes before Genentech had an oncology product) and then went on to launch Avastin, Rituxan, and Herceptin. I was there for the 25th anniversary party...guessing you were not.

So sure if you saying you worked at Genentech post the Roche buyout, that means you never really worked for Genentech, you worked for Roche, and after the buyout all the good people left - and yes that was 'big pharma', hence why all the good people left. Please don't confuse that with what was an amazing oncology biotech culture before the buyout...

Thanks for playing...any other 'startup biotechs' you worked at? And what I mean by that, is you were actually part of the 'start up' part...not the come in 5 to 10 years later part.
So yes I was there and launched one of those drugs before roche and xeloda came on which turned into big pharma. Let’s be honest that was more reflective of the time of pharma and less about the bio versus big. I spent time in big pharma around the mid- late 2000s which is as also a blast.
Was with Simon at Clovis which was great and then a few other places after. That should prove enough I have creditability if you actually have any credibility yourself. So yeah I have been from beginning at a few places

My point is bios cultures now aren’t that much better than some good big pharmas now. I go for money and I am honest about it and don’t use the cloud of “better culture”
 




So yes I was there and launched one of those drugs before roche and xeloda came on which turned into big pharma. Let’s be honest that was more reflective of the time of pharma and less about the bio versus big. I spent time in big pharma around the mid- late 2000s which is as also a blast.
Was with Simon at Clovis which was great and then a few other places after. That should prove enough I have creditability if you actually have any credibility yourself. So yeah I have been from beginning at a few places

My point is bios cultures now aren’t that much better than some good big pharmas now. I go for money and I am honest about it and don’t use the cloud of “better culture”

One of those products? Your timing is off, and no it does not give you any credibility it actually takes even more of it away as SC is most likely the dumbest, least respected and least liked person to have ever worked at Genetech. So, if you worked with him there(which would have made you late to the DNA party as I said before)and went to Clovis with him, you have told me all I need to know about your credibility.

You must be joking...Clovis was a disaster and Dale, Simon and Christy were as big of a reason as to why that culture was terrible. Perhaps the worst to come out of DNA. It also makes a lot of sense that someone who worked with Simon thinks mid to late big pharma was a blast. You are a complete tool to follow that guy anywhere once, let alone a second time...all of his endeavors post DNA have been disasters...guess that's why you are at Eisai...explains a ton.

Keep telling yourself that there are no longer any biotech cultural differences out there...you worked amongst the worst with the worst people.
 




One of those products? Your timing is off, and no it does not give you any credibility it actually takes even more of it away as SC is most likely the dumbest, least respected and least liked person to have ever worked at Genetech. So, if you worked with him there(which would have made you late to the DNA party as I said before)and went to Clovis with him, you have told me all I need to know about your credibility.

You must be joking...Clovis was a disaster and Dale, Simon and Christy were as big of a reason as to why that culture was terrible. Perhaps the worst to come out of DNA. It also makes a lot of sense that someone who worked with Simon thinks mid to late big pharma was a blast. You are a complete tool to follow that guy anywhere once, let alone a second time...all of his endeavors post DNA have been disasters...guess that's why you are at Eisai...explains a ton.

Keep telling yourself that there are no longer any biotech cultural differences out there...you worked amongst the worst with the worst people.

Wow you are angry….please read carefully. I worked at genentech and launched herceptin. I never said I worked for Simon as he came late in the 2000s (like I said earlier) and I left before that happened but I did at Clovis. Also worked for Kent later in my career. I know people and can name drop as well.

My whole point to my post was I have lived thru great bio cultures and crappy as well. Same for big pharma. Culture fluctuates everywhere and I don’t pretend to go places for culture. I go to launch products money/equity.

BTW there are lots of people that would disagree with you on those you have name dropped. Just sayin.
 




Wow you are angry….please read carefully. I worked at genentech and launched herceptin. I never said I worked for Simon as he came late in the 2000s (like I said earlier) and I left before that happened but I did at Clovis. Also worked for Kent later in my career. I know people and can name drop as well.

My whole point to my post was I have lived thru great bio cultures and crappy as well. Same for big pharma. Culture fluctuates everywhere and I don’t pretend to go places for culture. I go to launch products money/equity.

BTW there are lots of people that would disagree with you on those you have name dropped. Just sayin.

You know who wouldn’t disagree…Kent and Dennis.
 








IF, and that is a huge IF, you worked at DNA (which is what people who actually worked there abbreviate it as - not Gene) I guarantee you were there well after the Roche buyout...I worked on TPA (yes before Genentech had an oncology product) and then went on to launch Avastin, Rituxan, and Herceptin. I was there for the 25th anniversary party...guessing you were not.

So sure if you saying you worked at Genentech post the Roche buyout, that means you never really worked for Genentech, you worked for Roche, and after the buyout all the good people left - and yes that was 'big pharma', hence why all the good people left. Please don't confuse that with what was an amazing oncology biotech culture before the buyout...

Thanks for playing...any other 'startup biotechs' you worked at? And what I mean by that, is you were actually part of the 'start up' part...not the come in 5 to 10 years later part.
Now this has me interested; I launched TPA then TNK/cathflo then Bev to Atezo before I left. I had no idea there where more people here from Genentech. There were two others from Genentech that have left in the last 2 years with the same tenure as us.
 




Got a offer today from a big Pharma oncology company today and I must say, it sounds good, the people have been easy to deal with and it pays a 25% more, good benefits, car allowance of $750 plus .59 per mile. It's a job, any of these companies will fire you anytime they want to and not feel a thing. Stop being so noble because they do not care about you like you dream they do. Leave and watch and see if they call you like they are your friends. I promise, they will not call.
 












So what is left for Lenvima. Another company got good results in HCC so that one is dead. RCC-dead, DTC- maybe because it's a nothing indication, GYN-dead
We are going to buy something but it's secret, haha. If anything is getting bought, it is not us, we are too small to buy anything or anybody. I have been here 3 years and I have been here longer than anyone in my district. I guess is should leave
 




Got a offer today from a big Pharma oncology company today and I must say, it sounds good, the people have been easy to deal with and it pays a 25% more, good benefits, car allowance of $750 plus .59 per mile. It's a job, any of these companies will fire you anytime they want to and not feel a thing. Stop being so noble because they do not care about you like you dream they do. Leave and watch and see if they call you like they are your friends. I promise, they will not call.


Congratulations, but you are already at a Big Pharma with Eisai...you are just leaving a low paying one for a slightly better paying one comparatively speaking to where you are at, but most likely low compared to the higher end of the market.

In all sincerity good for you, smart moving on and getting out while growing your compensation. I have no doubts you will have better products, better leadership and a better culture.

In case you are interested here are some reference points from the higher paying biotech's that we have benched marked:

Salaries for tenured onc reps (10+ years) approx. $215K-$225K
IC - $60K at plan
Contests $10K a quarter budgeted for winners
Annual Cash LTI - $75K to $125K
Annual RSU's/Options - $100K in valuation
Monthly car allowance(pre tax) $1000
Milage IRS max 65.5 cents
Sign on bonus - average $25K with upper being $50K

So if you tabulate the above a tenured oncology rep at a upper echelon biotech can be pulling down $350K to $450K in total compensation in a year. This is how far Eisai is behind the better paying companies, hence why our oncology franchise is a revolving door. Eisai is where you come to get your oncology experience and then leave...or you are a C player with oncology experience and this is your only option.
 








Congratulations, but you are already at a Big Pharma with Eisai...you are just leaving a low paying one for a slightly better paying one comparatively speaking to where you are at, but most likely low compared to the higher end of the market.

In all sincerity good for you, smart moving on and getting out while growing your compensation. I have no doubts you will have better products, better leadership and a better culture.

In case you are interested here are some reference points from the higher paying biotech's that we have benched marked:

Salaries for tenured onc reps (10+ years) approx. $215K-$225K
IC - $60K at plan
Contests $10K a quarter budgeted for winners
Annual Cash LTI - $75K to $125K
Annual RSU's/Options - $100K in valuation
Monthly car allowance(pre tax) $1000
Milage IRS max 65.5 cents
Sign on bonus - average $25K with upper being $50K

So if you tabulate the above a tenured oncology rep at a upper echelon biotech can be pulling down $350K to $450K in total compensation in a year. This is how far Eisai is behind the better paying companies, hence why our oncology franchise is a revolving door. Eisai is where you come to get your oncology experience and then leave...or you are a C player with oncology experience and this is your only option.


Thanks for the insights. I’ve heard similar figures and it does truly show the disparity in compensation. This is motivational as me being a younger person to see that there is upside in this industry if you find the right place. I often wondered how some of my competitors were driving nice cars and living in crazy expensive neighborhoods. This makes total sense.

I see Eisai as a stepping stone to these types of jobs/companies, but clearly we can’t compete with these organizations from a compensation perspective.